S Bollani
Overview
Explore the profile of S Bollani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Persico M, Aglitti A, Aghemo A, Rendina M, Lleo A, Ciancio A, et al.
Aliment Pharmacol Ther
. 2018 May;
47(12):1705-1712.
PMID: 29722439
Background: The efficacy of direct-acting anti-viral (DAA) therapy in patients with a history of hepatocellular carcinoma (HCC) is unknown. Aim: We prospectively evaluated whether previously treated HCC affects DAA efficacy...
2.
Bruno S, Bollani S, Zignego A, Pascasio J, Magni C, Ciancio A, et al.
J Viral Hepat
. 2014 Oct;
22(5):469-80.
PMID: 25311757
In many countries, first-generation protease inhibitors (PIs)/peginterferon/ribavirin (P/R) still represent the only treatment option for HCV-infected patients. Subjects with advanced disease and previous failure to P/R urgently need therapy, but...
3.
Ardizzone S, Bollani S, Manzionna G, Colombo E, Maconi G, Imbesi V, et al.
Ann Ital Chir
. 2004 Jun;
74(6):621-5.
PMID: 15206802
Crohns Disease (CD) is a chronic intestinal inflammatory disease of unknown origins that cannot be definitely resolved with surgical intervention. Therefore, pharmacologic therapies are of great importance both in preventing...
4.
Pace F, Bollani S, MOLTENI P, Bianchi Porro G
Dig Liver Dis
. 2004 Mar;
36(2):111-5.
PMID: 15002817
Background And Aim: Ten years ago we published a study describing the 6-month outcome of 33 outpatients with typical gastro-oesophageal reflux disease symptoms and pH-metry proven excess gastro-oesophageal reflux but...
5.
Pace F, MOLTENI P, Bollani S, Sarzi-Puttini P, Stockbrugger R, Bianchi Porro G, et al.
Scand J Gastroenterol
. 2003 Nov;
38(10):1031-8.
PMID: 14621276
Background: Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are intestinal diseases perceived differently by patients and doctors: the former is considered essentially as an 'organic' disease (i.e. an...
6.
Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G
Dig Liver Dis
. 2003 Oct;
35(9):619-27.
PMID: 14563183
Background And Aims: The efficacy of azathioprine in the treatment of chronic active Crohn's disease is well established. However, this drug has a long onset of action. Methotrexate has also...
7.
Stockbrugger R, Schoon E, Bollani S, Mills P, Israeli E, Landgraf L, et al.
Aliment Pharmacol Ther
. 2002 Aug;
16(8):1519-27.
PMID: 12182752
Background: A high prevalence of osteoporosis has been noted in Crohn's disease, but data about fractures are scarce. Methods: The relationship between low bone mineral density and the prevalence of...
8.
Ardizzone S, Colombo E, Maconi G, Bollani S, Manzionna G, Petrone M, et al.
Dig Liver Dis
. 2002 Jul;
34(6):411-8.
PMID: 12132788
Background: Efficacy of infliximab in treatment of patients with moderate-to-severe refractory and fistulizing Crohn's disease has been shown in controlled clinical trials. Moreover, audit data from North America and North...
9.
Maconi G, Sampietro G, Russo A, Bollani S, Cristaldi M, Parente F, et al.
Gut
. 2002 Mar;
50(4):496-500.
PMID: 11889069
Aim: To evaluate the efficacy of power Doppler sonography (US) in depicting internal fistulae and their vascularity, and to study the characteristics of blood flow within the fistula wall. Patients...
10.
Parente F, Maconi G, Bollani S, Anderloni A, Sampietro G, Cristaldi M, et al.
Gut
. 2002 Mar;
50(4):490-5.
PMID: 11889068
Background And Aim: Despite the fact that bowel ultrasound (US) has recently been proved to be useful in the assessment of bowel diseases, uncertainty persists as to its diagnostic role...